PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
104 hedge funds and large institutions have $249M invested in Progenics Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
52% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 29
86% less call options, than puts
Call options by funds: $334K | Put options by funds: $2.47M
Holders
104
Holding in Top 10
1
Calls
$334K
Puts
$2.47M
Top Buyers
| 1 | +$12M | |
| 2 | +$1.69M | |
| 3 | +$1.02M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$912K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$539K |
Top Sellers
| 1 | -$3.94M | |
| 2 | -$1.66M | |
| 3 | -$1.61M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.58M |
| 5 |
PCM
Piermont Capital Management
St. Louis,
Missouri
|
-$1.55M |